FIELD: medicine.
SUBSTANCE: invention is a hemostatic sponge containing a base and iron salts as an active substance, characterized by the base and active substance being freeze-dried, while the sponge contains sodium alginate as the base, and iron sulfate as the active ingredient, the components in the sponge are in a certain ratio in the final aqueous solution, in the volume of 1 litre in %.
EFFECT: expanded assortment of hemostatic sponges with pronounced hemostatic action and exclusion of direct adverse effect of the active substance on the wound surface and surrounding tissues due to the pharmacological form of the sponge.
4 cl, 37 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HAEMOSTATIC SPONGE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2618896C1 |
| HEMOSTATIC SOLUTION BASED ON SULFUSATED POLYSACCHARIDES AND THE HEMOSTATIC SPONGES PRODUCTION FROM THIS SOLUTION (OPTIONS) | 2017 |
|
RU2652270C1 |
| HEMOSTATIC SPONGE AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2628809C1 |
| HEMOSTATIC COATING IN FORM OF SPONGE OR FILM (VERSIONS) | 2016 |
|
RU2639379C1 |
| HAEMOSTATIC POLYMER-BASED AGENT CONTAINING MICROPARTICLES AND IRON OXIDE NANOPARTICLES, AND METHODS FOR PREPARING PHARMACOLOGICAL FORMS THEREOF | 2020 |
|
RU2739490C1 |
| HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
| HEMOSTATIC COATING IN THE FORM OF POWDER | 2017 |
|
RU2660582C1 |
| HAEMOSTATIC AGENT | 2004 |
|
RU2275201C2 |
| HEMOSTATIC GLUE | 2004 |
|
RU2270015C1 |
| WOUND COVER WITH HEMOSTATIC ACTION, AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2624242C1 |
